TNFA
TNF Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website mymd.com
- Employees(FY) 6
- ISIN US62856X2018
Performance
-7.91%
1W
-10.44%
1M
-24.19%
3M
-49.06%
6M
-79.0%
YTD
-93.29%
1Y
Profile
MyMD Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
Technical Analysis of TNFA 2024-09-06
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-08-20 21:00
- 2024-07-23 21:05
- 2024-07-21 21:00
- 2024-07-14 19:52
- 2024-06-16 21:00
- 2024-05-20 21:00
- 2024-05-20 21:00
MyMD Pharmaceuticals Secures Strategic Investments(Businesswire)
- 2024-05-17 03:52
- 2024-04-08 20:21
Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today?(Investorplace)
- 2024-03-04 20:15
- 2024-02-12 22:45
- 2023-12-28 23:45
- 2023-12-05 20:15
- 2023-10-18 21:00
- 2023-10-03 19:30
- 2023-08-13 20:30
- 2023-08-01 20:30
- 2023-07-30 21:00
- 2023-04-11 20:30
- 2023-03-19 20:55
- 2023-03-07 19:30
- 2023-03-01 19:30
- 2023-02-27 19:30
- 2023-02-20 19:45
MyMD Announces $15 Million Offering with Existing Investors(Yahoo Finance)
- 2022-12-05 20:40
- 2022-11-16 19:00
- 2022-11-13 19:00
- 2022-09-19 20:00
- 2022-08-29 20:30
- 2022-08-02 21:45
Page 1 of 3
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.